동물용 분자진단 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Veterinary Molecular Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 6,944,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,142,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,810,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 이번에 세계의 동물용 분자진단 시장에 관한 광범위한 조사 리포트를 출판하며, 촉진력, 새로운 동향, 기회, 과제 등 주요 시장 역학의 철저한 분석을 제공했습니다. 본 리포트는 시장 구도를 종합적으로 이해하고, 이해관계자가 충분한 정보에 기반한 의사결정을 시행할 수 있도록 지원합니다.

주요 인사이트

• 동물용 분자진단 시장 규모(2024년) : 2억 1,470만 달러
• 시장 예측 금액(2033년) : 4억 3,770만 달러
• 세계 시장 성장률(CAGR 2024-2033년) : 8.2%

동물용 분자진단 시장 - 조사 범위 :

동물용 분자진단 시장은 동물의 질병을 정확하게 검출하고 분석하는 데 사용되는 일련의 첨단 진단 기술을 포괄합니다. 이러한 기술에는 중합효소연쇄반응(PCR), 차세대 염기서열분석(NGS) 및 다양한 수의학 질환의 진단에 높은 민감도와 특이성을 제공하는 기타 분자 방법이 포함됩니다. 분자진단법은 반려동물과 가축의 병원체, 유전적 질병 및 기타 건강 문제를 식별하고 질병 관리 및 치료 결과를 개선하는 데 매우 중요합니다. 이 시장은 분자생물학의 발전, 인수공통전염병 증가, 신속하고 정확한 진단 솔루션에 대한 수요 증가에 힘입어 성장하고 있습니다.

시장 성장의 촉진요인:

세계 동물용 분자진단 시장은 동물의 감염성 질환 발병률 증가, 반려동물 사육 증가, 동물 건강에 대한 인식 증가 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 분자진단은 정확하고 시기적절한 결과를 제공하여 효과적인 질병 관리 및 예방에 필수적입니다. 또한 동물 의료 인프라의 확충과 휴대가 간편하고 사용하기 쉬운 진단 기기의 개발 등 진단 기술의 발전도 시장 성장에 기여하고 있습니다. 또한 분자진단과 원격의료 및 디지털 건강 솔루션의 통합으로 접근성과 보급이 확대되고 있습니다.

시장 성장 억제요인 :

유망한 성장세에도 불구하고, 동물용 분자진단 시장은 첨단 진단 기술에 따른 높은 비용과 전문 지식의 필요성이라는 과제에 직면해 있습니다. 특히 소규모 동물병원의 경우, 분자진단을 도입하는 데 필요한 초기 투자비용이 큰 부담이 될 수 있습니다. 또한 분자진단 검사의 표준화 및 규제에 대한 우려로 인해 도입과 신뢰성에 영향을 미칠 수 있습니다. 이러한 문제를 해결하기 위해서는 지속적인 기술 발전, 비용 효율적인 솔루션, 명확한 규제 프레임워크가 필요하며, 이를 통해 동물 의학에서 분자진단의 광범위한 수용과 효과를 보장할 수 있습니다.

시장 기회 :

동물용 분자진단 시장은 기술 혁신과 진화하는 수의학적 요구로 인해 큰 성장 기회를 맞이하고 있습니다. 맞춤형 수의학에 대한 관심이 높아지면서 새로운 진단 분석법 및 플랫폼 시장 개척은 시장 확대의 새로운 길을 열어주고 있습니다. 질병의 조기 발견 및 예방에 대한 수요 증가와 반려동물의 인간화 추세는 첨단 분자진단의 채택을 촉진할 것으로 예상됩니다. 이러한 기회를 활용하고 시장 성장을 가속하기 위해서는 전략적 파트너십, R&D 투자, 통합 진단 솔루션 도입이 매우 중요합니다.

이 보고서에서 다룬 주요 질문

• 세계 동물용 분자진단 시장의 성장을 가속하는 주요 요인은?
• 동물용 분자진단의 채택을 주도하는 용도와 지역은?
• 기술 발전은 수의학 분자진단 시장 경쟁 구도를 어떻게 재편하고 있는가?
• 동물용 분자진단 시장의 주요 기업은 어디에 있으며, 경쟁력을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 동물용 분자진단 시장의 새로운 동향과 전망은?

목차

제1장 개요

제2장 시장 개요

• 시장 범위/분류
• 시장의 정의/범위/제한
• 포함 사항·제외 사항

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 시장의 혁신/개발 동향

제4장 주요 성공 요인

• 주요 프로모션 전략 : 제조업체별
• 주요 규제
• PESTEL 분석
• Porter의 산업 분석
• 제품 발매 활동
• 제품 채택/사용 상황 분석
• 제품 USP/특징
• 생산 분석 : 지역별
• 환불 시나리오
• 거래 분석
• 밸류체인 분석

제5장 시장 배경

• 거시경제 요인
• 예측 요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 제품별
  • 질환별
  • 유형별
  • 최종사용자별
  • 국가별
• 2024년 시장 시나리오

제7장 세계 시장 수요(금액 또는 규모, 백만 달러) 분석

• 과거 시장 금액(백만 달러) 분석, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 시장 분류별, 2024-2033년
  • 전년대비 성장 동향 분석
  • 절대액 기회 분석

제8장 세계 시장 분석 : 제품별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 제품별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 제품별, 2024-2033년
  • PCR 키트
  • INAAT 키트
  • 마이크로어레이 키트
  • DNA 시퀀싱 키트
• 시장의 매력 분석 : 제품별

제9장 세계 시장 분석 : 질환별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 질환별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 질환별, 2024-2033년
  • Anaplasma spp.
  • Ehrlichia spp.
  • 뉴캐슬병
  • 인플루엔자
  • 돼지생식기호흡기증후군(PRRS)
  • 기타
• 시장의 매력 분석 : 질환별

제10장 세계 시장 분석 : 유형별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 유형별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 유형별, 2024-2033년
  • 가축
  • 애완동물
• 시장의 매력 분석 : 유형별

제11장 세계 시장 분석 : 최종사용자별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 최종사용자별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 최종사용자별, 2024-2033년
  • 동물병원
  • 임상 검사실
  • 수의학 연구기관
• 시장의 매력 분석 : 최종사용자별

제12장 세계 시장 분석 : 지역별

• 서론/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 지역별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석 예측 : 지역별, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 동아시아
  • 남아시아
  • 오세아니아
  • 중동 및 아프리카
• 시장의 매력 분석 : 지역별

제13장 북미 시장 분석

제14장 라틴아메리카 시장 분석

제15장 유럽 시장 분석

제16장 동아시아 시장 분석

제17장 남아시아 시장 분석

제18장 오세아니아 시장 분석

제19장 중동 및 아프리카(MEA) 시장 분석

제20장 시장 구조 분석

• 시장 분석 : 기업 계층별
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제21장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마킹
• 경쟁 상세 정보
  • bioMerieux SA
  • IDEXX Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Qiagen NV
  • Neogen Corporation
  • ID. Vet
  • INDICAL BIOSCIENCE GmbH
  • Veterinary Molecular Diagnostics, Inc.

제22장 사용되는 전제 조건과 두자어

제23장 조사 방법

KSA

영문 목차

영문목차

Persistence Market Research has recently published an extensive report on the global Veterinary Molecular Diagnostics market, providing a thorough analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report delivers a comprehensive understanding of the market landscape, helping stakeholders make informed decisions.

Key Insights:

• Veterinary Molecular Diagnostics Market Size (2024E): USD 214.7 Mn
• Projected Market Value (2033F): USD 437.7 Mn
• Global Market Growth Rate (CAGR 2024 to 2033): 8.2%

Veterinary Molecular Diagnostics Market - Report Scope:

The Veterinary Molecular Diagnostics market encompasses a range of advanced diagnostic technologies used for the precise detection and analysis of diseases in animals. These technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS), and other molecular methods that offer high sensitivity and specificity for diagnosing various veterinary conditions. Molecular diagnostics are crucial for identifying pathogens, genetic disorders, and other health issues in pets and livestock, leading to improved disease management and treatment outcomes. The market is driven by advancements in molecular biology, the increasing prevalence of zoonotic diseases, and the growing demand for rapid and accurate diagnostic solutions.

Market Growth Drivers:

The global Veterinary Molecular Diagnostics market is propelled by several key factors, including the rising incidence of infectious diseases in animals, increased pet ownership, and growing awareness about animal health. Molecular diagnostics offer precise and timely results, which are essential for effective disease management and prevention. The expansion of veterinary healthcare infrastructure and advancements in diagnostic technologies, such as the development of portable and user-friendly diagnostic devices, are also contributing to the market's growth. Additionally, the integration of molecular diagnostics with telemedicine and digital health solutions is enhancing their accessibility and adoption.

Market Restraints:

Despite its promising growth, the Veterinary Molecular Diagnostics market faces challenges such as high costs associated with advanced diagnostic technologies and the need for specialized expertise. The initial investment required for implementing molecular diagnostics in veterinary practices can be significant, especially for smaller clinics. Additionally, there are concerns related to the standardization and regulation of molecular diagnostic tests, which can impact their adoption and reliability. Addressing these challenges requires ongoing advancements in technology, cost-effective solutions, and clear regulatory frameworks to ensure the broad acceptance and effectiveness of molecular diagnostics in veterinary care.

Market Opportunities:

The Veterinary Molecular Diagnostics market presents significant growth opportunities driven by technological innovations and evolving veterinary needs. The development of novel diagnostic assays and platforms, along with the increasing focus on personalized veterinary care, is opening new avenues for market expansion. The rising demand for early disease detection and prevention, coupled with the growing trend of pet humanization, is expected to drive the adoption of advanced molecular diagnostics. Strategic partnerships, investments in R&D, and the introduction of integrated diagnostic solutions will be crucial for companies looking to capitalize on these opportunities and drive market growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Veterinary Molecular Diagnostics market globally?
• Which applications and regions are leading the adoption of Veterinary Molecular Diagnostics?
• How are technological advancements reshaping the competitive landscape of the Veterinary Molecular Diagnostics market?
• Who are the key players in the Veterinary Molecular Diagnostics market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Veterinary Molecular Diagnostics market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Veterinary Molecular Diagnostics market, such as IDEXX Laboratories, Neogen Corporation, and Zoetis, are focusing on innovation, technological advancements, and strategic collaborations to maintain a competitive edge. These companies are investing heavily in R&D to develop cutting-edge diagnostic solutions that improve animal health and streamline veterinary practices. Partnerships with research institutions, technology providers, and healthcare organizations are essential for expanding market reach and enhancing diagnostic capabilities. Emphasizing accuracy, cost-effectiveness, and comprehensive diagnostic solutions are key strategies for sustaining leadership in the rapidly evolving Veterinary Molecular Diagnostics market.

Key Companies Profiled:

• bioMerieux SA
• IDEXX Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Qiagen N.V.
• Neogen Corporation
• ID. Vet
• INDICAL BIOSCIENCE GmbH
• Veterinary Molecular Diagnostics, Inc.

Key Segments Covered in Veterinary molecular diagnostics Industry Research

Product

• PCR Kits
• INAAT Kits
• Microarray Kits
• DNA Sequencing Kits

Disease

• Anaplasma spp.
• Ehrlichia spp.
• New Castle Disease
• Influenza
• Porcine Reproductive & Respiratory Syndrome (PRRS)

Species

• Livestock Animals
• Companion Animals

End User

• Veterinary Hospitals
• Clinical Laboratories
• Veterinary Research Institutes

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Market Innovation / Development Trends

4. Key Success Factors

• 4.1. Key Promotional Strategies, by Manufacturers
• 4.2. Key Regulations
• 4.3. PESTEL Analysis
• 4.4. Porter's Analysis
• 4.5. Product Launch Activities
• 4.6. Product Adoption/Usage Analysis
• 4.7. Product USPs/ Features
• 4.8. Production Analysis by Region
• 4.9. Reimbursement Scenario
• 4.10. Trade Analysis
• 4.11. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Veterinary Diagnostics Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Increasing Strategic Collaborations Among Key Players
  • 5.2.2. Rise in Awareness About Diseases in Animals Worldwide
  • 5.2.3. High Adoption of Molecular Diagnostic Kits for Veterinary Diseases
  • 5.2.4. Higher Prevalence of Chronic & Infectious Diseases in Animals
  • 5.2.5. Advancements in Molecular Technology
  • 5.2.6. Growing Acceptance of Advanced Molecular Diagnostic Techniques
  • 5.2.7. Ease in FDA Clearance for Veterinary Products
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Disease
  • 6.1.3. By Species
  • 6.1.4. By End User
  • 6.1.5. By Country
• 6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product, 2024-2033
  • 8.3.1. PCR Kits
    • 8.3.1.1. RT-PCR Kits
    • 8.3.1.2. RAPD-PCR Kits
  • 8.3.2. INAAT Kits
  • 8.3.3. Microarray Kits
  • 8.3.4. DNA Sequencing Kits
• 8.4. Market Attractiveness Analysis by Product

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Disease

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2024-2033
  • 9.3.1. Anaplasma spp.
  • 9.3.2. Ehrlichia spp.
  • 9.3.3. New Castle Disease
  • 9.3.4. Influenza
  • 9.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
  • 9.3.6. Others
• 9.4. Market Attractiveness Analysis by Disease

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Species

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis by Species, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Species, 2024-2033
  • 10.3.1. Livestock Animals
    • 10.3.1.1. Porcine
    • 10.3.1.2. Poultry
    • 10.3.1.3. Bovine/Cattle
    • 10.3.1.4. Aquatic
    • 10.3.1.5. Ovine
  • 10.3.2. Companion Animals
    • 10.3.2.1. Canine
    • 10.3.2.2. Feline
    • 10.3.2.3. Avian
• 10.4. Market Attractiveness Analysis by Species

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
  • 11.3.1. Veterinary Hospitals
  • 11.3.2. Clinical Laboratories
  • 11.3.3. Veterinary Research Institutes
• 11.4. Market Attractiveness Analysis by End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis Forecast by Region, 2024-2033
  • 12.3.1. North America
  • 12.3.2. Latin America
  • 12.3.3. Europe
  • 12.3.4. East Asia
  • 12.3.5. South Asia
  • 12.3.6. Oceania
  • 12.3.7. Middle East & Africa
• 12.4. Market Attractiveness Analysis by Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. U.S.
    • 13.3.1.2. Canada
  • 13.3.2. By Product
  • 13.3.3. By Disease
  • 13.3.4. By Species
  • 13.3.5. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Disease
  • 13.4.4. By Species
  • 13.4.5. By End User
• 13.5. Market Trends
• 13.6. Key Market Participants - Intensity Mapping
• 13.7. Drivers and Restraints - Impact Analysis
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. U.S. Market
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By Disease
      • 13.8.1.2.3. By Species
      • 13.8.1.2.4. By End User
  • 13.8.2. Canada Market
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By Disease
      • 13.8.2.2.3. By Species
      • 13.8.2.2.4. By End User

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. Mexico
    • 14.3.1.2. Brazil
    • 14.3.1.3. Argentina
    • 14.3.1.4. Rest of Latin America
  • 14.3.2. By Product
  • 14.3.3. By Disease
  • 14.3.4. By Species
  • 14.3.5. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Disease
  • 14.4.4. By Species
  • 14.4.5. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. Mexico Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Disease
      • 14.8.1.2.3. By Species
      • 14.8.1.2.4. By End User
  • 14.8.2. Brazil Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Disease
      • 14.8.2.2.3. By Species
      • 14.8.2.2.4. By End User
  • 14.8.3. Argentina Market Analysis
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By Disease
      • 14.8.3.2.3. By Species
      • 14.8.3.2.4. By End User

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Germany
    • 15.3.1.2. Italy
    • 15.3.1.3. France
    • 15.3.1.4. U.K.
    • 15.3.1.5. Spain
    • 15.3.1.6. BENELUX
    • 15.3.1.7. Russia
    • 15.3.1.8. Rest of Europe
  • 15.3.2. By Product
  • 15.3.3. By Disease
  • 15.3.4. By Species
  • 15.3.5. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Disease
  • 15.4.4. By Species
  • 15.4.5. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. Germany Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Disease
      • 15.8.1.2.3. By Species
      • 15.8.1.2.4. By End User
  • 15.8.2. Italy Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Disease
      • 15.8.2.2.3. By Species
      • 15.8.2.2.4. By End User
  • 15.8.3. France Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Disease
      • 15.8.3.2.3. By Species
      • 15.8.3.2.4. By End User
  • 15.8.4. U.K. Market Analysis
    • 15.8.4.1. Introduction
    • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.4.2.1. By Product
      • 15.8.4.2.2. By Disease
      • 15.8.4.2.3. By Species
      • 15.8.4.2.4. By End User
  • 15.8.5. Spain Market Analysis
    • 15.8.5.1. Introduction
    • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.5.2.1. By Product
      • 15.8.5.2.2. By Disease
      • 15.8.5.2.3. By Species
      • 15.8.5.2.4. By End User
  • 15.8.6. BENELUX Market Analysis
    • 15.8.6.1. Introduction
    • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.6.2.1. By Product
      • 15.8.6.2.2. By Disease
      • 15.8.6.2.3. By Species
      • 15.8.6.2.4. By End User
  • 15.8.7. Russia Market Analysis
    • 15.8.7.1. Introduction
    • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.7.2.1. By Product
      • 15.8.7.2.2. By Disease
      • 15.8.7.2.3. By Species
      • 15.8.7.2.4. By End User

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. China
    • 16.3.1.2. Japan
    • 16.3.1.3. South Korea
  • 16.3.2. By Product
  • 16.3.3. By Disease
  • 16.3.4. By Species
  • 16.3.5. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Disease
  • 16.4.4. By Species
  • 16.4.5. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. China Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Disease
      • 16.8.1.2.3. By Species
      • 16.8.1.2.4. By End User
  • 16.8.2. Japan Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Disease
      • 16.8.2.2.3. By Species
      • 16.8.2.2.4. By End User
  • 16.8.3. South Korea Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Disease
      • 16.8.3.2.3. By Species
      • 16.8.3.2.4. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Indonesia
    • 17.3.1.3. Malaysia
    • 17.3.1.4. Thailand
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Product
  • 17.3.3. By Disease
  • 17.3.4. By Species
  • 17.3.5. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Disease
  • 17.4.4. By Species
  • 17.4.5. By End User
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. India Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Disease
      • 17.8.1.2.3. By Species
      • 17.8.1.2.4. By End User
  • 17.8.2. Indonesia Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Disease
      • 17.8.2.2.3. By Species
      • 17.8.2.2.4. By End User
  • 17.8.3. Malaysia Market Analysis
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By Disease
      • 17.8.3.2.3. By Species
      • 17.8.3.2.4. By End User
  • 17.8.4. Thailand Market Analysis
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.4.2.1. By Product
      • 17.8.4.2.2. By Disease
      • 17.8.4.2.3. By Species
      • 17.8.4.2.4. By End User

18. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. Australia
    • 18.3.1.2. New Zealand
  • 18.3.2. By Product
  • 18.3.3. By Disease
  • 18.3.4. By Species
  • 18.3.5. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Disease
  • 18.4.4. By Species
  • 18.4.5. By End User
• 18.5. Market Trends
• 18.6. Key Market Participants - Intensity Mapping
• 18.7. Drivers and Restraints - Impact Analysis
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. Australia Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Disease
      • 18.8.1.2.3. By Species
      • 18.8.1.2.4. By End User
  • 18.8.2. New Zealand Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Disease
      • 18.8.2.2.3. By Species
      • 18.8.2.2.4. By End User

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) Analysis Trend Analysis by Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. GCC Countries
    • 19.3.1.2. Turkiye
    • 19.3.1.3. North Africa
    • 19.3.1.4. South Africa
    • 19.3.1.5. Rest of Middle East and Africa
  • 19.3.2. By Product
  • 19.3.3. By Disease
  • 19.3.4. By Species
  • 19.3.5. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Disease
  • 19.4.4. By Species
  • 19.4.5. By End User
• 19.5. Market Trends
• 19.6. Key Market Participants - Intensity Mapping
• 19.7. Drivers and Restraints - Impact Analysis
• 19.8. Country Level Analysis & Forecast
  • 19.8.1. GCC Countries Market Analysis
    • 19.8.1.1. Introduction
    • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.1.2.1. By Product
      • 19.8.1.2.2. By Disease
      • 19.8.1.2.3. By Species
      • 19.8.1.2.4. By End User
  • 19.8.2. Turkiye Market Analysis
    • 19.8.2.1. Introduction
    • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.2.2.1. By Product
      • 19.8.2.2.2. By Disease
      • 19.8.2.2.3. By Species
      • 19.8.2.2.4. By End User
  • 19.8.3. South Africa Market Analysis
    • 19.8.3.1. Introduction
    • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.3.2.1. By Product
      • 19.8.3.2.2. By Disease
      • 19.8.3.2.3. By Species
      • 19.8.3.2.4. By End User
  • 19.8.4. North Africa Market Analysis
    • 19.8.4.1. Introduction
    • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 19.8.4.2.1. By Product
      • 19.8.4.2.2. By Disease
      • 19.8.4.2.3. By Species
      • 19.8.4.2.4. By End User

20. Market Structure Analysis

• 20.1. Market Analysis by Tier of Companies
• 20.2. Market Share Analysis of Top Players
• 20.3. Market Presence Analysis

21. Competition Analysis

• 21.1. Competition Dashboard
• 21.2. Competition Benchmarking
• 21.3. Competition Deep Dive
  • 21.3.1. bioMerieux SA
    • 21.3.1.1. Overview
    • 21.3.1.2. Product Portfolio
    • 21.3.1.3. Sales Footprint
    • 21.3.1.4. Key Financials
    • 21.3.1.5. SWOT Analysis
    • 21.3.1.6. Key Developments
    • 21.3.1.7. Strategy Overview
      • 21.3.1.7.1. Marketing Strategy
      • 21.3.1.7.2. Product Strategy
      • 21.3.1.7.3. Channel Strategy
  • 21.3.2. IDEXX Laboratories, Inc.
    • 21.3.2.1. Overview
    • 21.3.2.2. Product Portfolio
    • 21.3.2.3. Sales Footprint
    • 21.3.2.4. Key Financials
    • 21.3.2.5. SWOT Analysis
    • 21.3.2.6. Key Developments
    • 21.3.2.7. Strategy Overview
      • 21.3.2.7.1. Marketing Strategy
      • 21.3.2.7.2. Product Strategy
      • 21.3.2.7.3. Channel Strategy
  • 21.3.3. Thermo Fisher Scientific Inc.
    • 21.3.3.1. Overview
    • 21.3.3.2. Product Portfolio
    • 21.3.3.3. Sales Footprint
    • 21.3.3.4. Key Financials
    • 21.3.3.5. SWOT Analysis
    • 21.3.3.6. Key Developments
    • 21.3.3.7. Strategy Overview
      • 21.3.3.7.1. Marketing Strategy
      • 21.3.3.7.2. Product Strategy
      • 21.3.3.7.3. Channel Strategy
  • 21.3.4. Qiagen N.V.
    • 21.3.4.1. Overview
    • 21.3.4.2. Product Portfolio
    • 21.3.4.3. Sales Footprint
    • 21.3.4.4. Key Financials
    • 21.3.4.5. SWOT Analysis
    • 21.3.4.6. Key Developments
    • 21.3.4.7. Strategy Overview
      • 21.3.4.7.1. Marketing Strategy
      • 21.3.4.7.2. Product Strategy
      • 21.3.4.7.3. Channel Strategy
  • 21.3.5. Neogen Corporation
    • 21.3.5.1. Overview
    • 21.3.5.2. Product Portfolio
    • 21.3.5.3. Sales Footprint
    • 21.3.5.4. Key Financials
    • 21.3.5.5. SWOT Analysis
    • 21.3.5.6. Key Developments
    • 21.3.5.7. Strategy Overview
      • 21.3.5.7.1. Marketing Strategy
      • 21.3.5.7.2. Product Strategy
      • 21.3.5.7.3. Channel Strategy
  • 21.3.6. ID. Vet
    • 21.3.6.1. Overview
    • 21.3.6.2. Product Portfolio
    • 21.3.6.3. Sales Footprint
    • 21.3.6.4. Key Financials
    • 21.3.6.5. SWOT Analysis
    • 21.3.6.6. Key Developments
    • 21.3.6.7. Strategy Overview
      • 21.3.6.7.1. Marketing Strategy
      • 21.3.6.7.2. Product Strategy
      • 21.3.6.7.3. Channel Strategy
  • 21.3.7. INDICAL BIOSCIENCE GmbH
    • 21.3.7.1. Overview
    • 21.3.7.2. Product Portfolio
    • 21.3.7.3. Sales Footprint
    • 21.3.7.4. Key Financials
    • 21.3.7.5. SWOT Analysis
    • 21.3.7.6. Key Developments
    • 21.3.7.7. Strategy Overview
      • 21.3.7.7.1. Marketing Strategy
      • 21.3.7.7.2. Product Strategy
      • 21.3.7.7.3. Channel Strategy
  • 21.3.8. Veterinary Molecular Diagnostics, Inc.
    • 21.3.8.1. Overview
    • 21.3.8.2. Product Portfolio
    • 21.3.8.3. Sales Footprint
    • 21.3.8.4. Key Financials
    • 21.3.8.5. SWOT Analysis
    • 21.3.8.6. Key Developments
    • 21.3.8.7. Strategy Overview
      • 21.3.8.7.1. Marketing Strategy
      • 21.3.8.7.2. Product Strategy
      • 21.3.8.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology

관련자료